GlassScriptPhysician profile
George D Grice
NPI 1902918147
$1,312.59
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $563 · 2021: $407 · 2022: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $478.33 | 2020 | |
| Allergan, INC. | $349.07 | 2019-2022 | |
| Stryker Corporation | $155.62 | 2021 | |
| Tela Bio, INC. | $79.85 | 2019-2022 | |
| Abbott Laboratories | $50.00 | 2019-2022 | |
| Integra Lifesciences Corporation | $39.09 | 2020-2021 | |
| Medtronic, INC. | $26.21 | 2021-2022 | |
| Covidien LP | $25.18 | 2019 | |
| Heron Therapeutics, INC. | $23.97 | 2021 | |
| Innocoll Pharmaceuticals Limited | $23.13 | 2021 | |
| Checkpoint Surgical, INC | $16.37 | 2022 | |
| Tei Biosciences INC | $15.49 | 2019 | |
| Davol INC. | $15.37 | 2022 | |
| Olympus America INC. | $14.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Grice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.